Portolan Capital Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,135,613
| Closed | -$4.72M | – | 133 |
|
|
2024
Q4 | $4.72M | Sell |
1,135,613
-167,825
| -13% | -$698K | 0.32% | 94 |
|
|
2024
Q3 | $5.07M | Sell |
1,303,438
-384,212
| -23% | -$1.49M | 0.37% | 82 |
|
|
2024
Q2 | $6.62M | Sell |
1,687,650
-34,127
| -2% | -$134K | 0.54% | 66 |
|
|
2024
Q1 | $7.21M | Sell |
1,721,777
-1,035,472
| -38% | -$4.34M | 0.55% | 68 |
|
|
2023
Q4 | $13M | Buy |
2,757,249
+613,583
| +29% | +$2.88M | 1.13% | 24 |
|
|
2023
Q3 | $6.69M | Buy |
2,143,666
+493,789
| +30% | +$1.54M | 0.63% | 49 |
|
|
2023
Q2 | $7.57M | Buy |
1,649,877
+1,028,263
| +165% | +$4.72M | 0.67% | 42 |
|
|
2023
Q1 | $3.08M | Buy |
+621,614
| New | +$3.08M | 0.29% | 100 |
|